MOLEQLAR
PrivateLast Round
Seed
Nov 9, 2023
Company Overview
MOLEQLAR is a biotechnology and food company that develops and distributes science-based longevity products including nutritional supplements and health tests.
Sector
Healthcare & Life Sciences
Verticals
D2C Brands, Biotechnology, E-commerce, Precision Medicine, Subscription Commerce
Business Model
B2C
Customer Profile
Subscription SaaS, Services & Consulting, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MOLEQLAR Comps
Public and private peers based on sector, stage, and business model.
MOLEQLAR Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 9, 2023 |
Key People
Founding team and executive leadership
MOLEQLAR Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rheingau Founders | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 23, 2025
Grew 36% QoQ, from 11 to 15 employees.
- Jun 7, 2025
Grew 30% QoQ, from 10 to 13 employees.
MOLEQLAR Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MOLEQLAR's valuation, stock price, and market status.
